| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |